Ancilia Biosciences, Inc. — Form D
Ancilia Biosciences, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2023-05-04. The offering totals $5.0M, of which $1.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-05-04
- Form: D
- Accession: 0001975776-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $1.0M
- Remaining: $4.0M
- Investors: 2
- Date of first sale: 2023-04-13
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-480881
Issuer
- Name: Ancilia Biosciences, Inc.
- CIK: 0001975776
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 3960 BROADWAY, 6TH FLOOR, NEW YORK, NY, 10032
- Phone: 716-474-6710
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Rodolphe Barrangou | Director | LONG ISLAND CITY, NY |
| Dale Pfost | Director | LONG ISLAND CITY, NY |
| Alexandra Sakatos | Director | LONG ISLAND CITY, NY |
| Rodolphe Barrangou | Executive Officer | LONG ISLAND CITY, NY |
| Alexandra Sakatos | Executive Officer | LONG ISLAND CITY, NY |
| Vera Schroeder | Related Person | LONG ISLAND CITY, NY |
| Dale Pfost | Related Person | LONG ISLAND CITY, NY |
| Rodolphe Barrangou | Related Person | LONG ISLAND CITY, NY |
| Gurdane Bhutani | Related Person | Claymont, DE |
| Alexandra Sakatos | Related Person | LONG ISLAND CITY, NY |
Other filings by this issuer (1)
More